FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1863484212> ?p ?o ?g. }

• W1863484212 endingPage "11693" @default.
• W1863484212 startingPage "11683" @default.
• W1863484212 abstract "// Jérémie Nsengimana 1 , Jon Laye 1 , Anastasia Filia 2 , Christy Walker 1 , Rosalyn Jewell 3 , Joost J. Van den Oord 4,9 , Pascal Wolter 5 , Poulam Patel 6,9 , Antje Sucker 7 , Dirk Schadendorf 7,9 , Göran B. Jönsson 8 , D. Timothy Bishop 1 and Julia Newton-Bishop 1 1 Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK 2 National Heart and Lung Institute, Imperial College, London, UK 3 Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK 4 Department of Pathology, University Hospitals Leuven, Leuven, Belgium 5 Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium 6 School of Medicine, University of Nottingham, Nottingham, UK 7 Department of Dermatology, Essen University Hospital, Essen, and German Consortium of Translational Cancer Research (DKTK), Heidelberg, Germany 8 Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden 9 European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group,  Brussels, Belgium Correspondence to: Jérémie Nsengimana, email: // Keywords : molecular subtype, AJCC stage, ROC analysis, vitamin D, telomere length Received : January 12, 2015 Accepted : February 10, 2015 Published : March 12, 2015 Abstract Development and validation of robust molecular biomarkers has so far been limited in melanoma research. In this paper we used a large population-based cohort to replicate two published gene signatures for melanoma classification. We assessed the signatures prognostic value and explored their biological significance by correlating them with factors known to be associated with survival (vitamin D) or etiological routes (nevi, sun sensitivity and telomere length). Genomewide microarray gene expressions were profiled in 300 archived tumors (224 primaries, 76 secondaries). The two gene signatures classified up to 96% of our samples and showed strong correlation with melanoma specific survival (P=3x10 -4 ), Breslow thickness (P=5x10 -10 ), ulceration (P=9.x10 -8 ) and mitotic rate (P=3x10 -7 ), adding prognostic value over AJCC stage (adjusted hazard ratio 1.79, 95%CI 1.13-2.83), as previously reported. Furthermore, molecular subtypes were associated with season-adjusted serum vitamin D at diagnosis (P=0.04) and genetically predicted telomere length (P=0.03). Specifically, molecular high-grade tumors were more frequent in patients with lower vitamin D levels whereas high immune tumors came from patients with predicted shorter telomeres. Our data confirm the utility of molecular biomarkers in melanoma prognostic estimation using tiny archived specimens and shed light on biological mechanisms likely to impact on cancer initiation and progression." @default.
• W1863484212 created "2016-06-24" @default.
• W1863484212 creator A5012814808 @default.
• W1863484212 creator A5014802766 @default.
• W1863484212 creator A5018344543 @default.
• W1863484212 creator A5027879841 @default.
• W1863484212 creator A5034365278 @default.
• W1863484212 creator A5044801113 @default.
• W1863484212 creator A5045950154 @default.
• W1863484212 creator A5049279715 @default.
• W1863484212 creator A5054489737 @default.
• W1863484212 creator A5081844624 @default.
• W1863484212 creator A5086784384 @default.
• W1863484212 creator A5087007057 @default.
• W1863484212 creator A5090210646 @default.
• W1863484212 date "2015-03-12" @default.
• W1863484212 modified "2023-09-25" @default.
• W1863484212 title "Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort" @default.
• W1863484212 cites W1920185723 @default.
• W1863484212 cites W1967954493 @default.
• W1863484212 cites W1971228613 @default.
• W1863484212 cites W1986839431 @default.
• W1863484212 cites W1996965698 @default.
• W1863484212 cites W2001348339 @default.
• W1863484212 cites W2012079618 @default.
• W1863484212 cites W2013797350 @default.
• W1863484212 cites W2020016182 @default.
• W1863484212 cites W2044437847 @default.
• W1863484212 cites W2048398251 @default.
• W1863484212 cites W2091014158 @default.
• W1863484212 cites W2095826876 @default.
• W1863484212 cites W2102931534 @default.
• W1863484212 cites W2106608030 @default.
• W1863484212 cites W2106699470 @default.
• W1863484212 cites W2110457899 @default.
• W1863484212 cites W2113032639 @default.
• W1863484212 cites W2118863192 @default.
• W1863484212 cites W2125882492 @default.
• W1863484212 cites W2128035403 @default.
• W1863484212 cites W2128542677 @default.
• W1863484212 cites W2131482305 @default.
• W1863484212 cites W2134878419 @default.
• W1863484212 cites W2149635248 @default.
• W1863484212 cites W2152032358 @default.
• W1863484212 cites W2153562609 @default.
• W1863484212 cites W2159182432 @default.
• W1863484212 cites W2159686118 @default.
• W1863484212 cites W2160381920 @default.
• W1863484212 cites W2164808240 @default.
• W1863484212 doi "https://doi.org/10.18632/oncotarget.3549" @default.
• W1863484212 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4484486" @default.
• W1863484212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25871393" @default.
• W1863484212 hasPublicationYear "2015" @default.
• W1863484212 type Work @default.
• W1863484212 sameAs 1863484212 @default.
• W1863484212 citedByCount "44" @default.
• W1863484212 countsByYear W18634842122016 @default.
• W1863484212 countsByYear W18634842122017 @default.
• W1863484212 countsByYear W18634842122018 @default.
• W1863484212 countsByYear W18634842122019 @default.
• W1863484212 countsByYear W18634842122020 @default.
• W1863484212 countsByYear W18634842122021 @default.
• W1863484212 countsByYear W18634842122022 @default.
• W1863484212 countsByYear W18634842122023 @default.
• W1863484212 crossrefType "journal-article" @default.
• W1863484212 hasAuthorship W1863484212A5012814808 @default.
• W1863484212 hasAuthorship W1863484212A5014802766 @default.
• W1863484212 hasAuthorship W1863484212A5018344543 @default.
• W1863484212 hasAuthorship W1863484212A5027879841 @default.
• W1863484212 hasAuthorship W1863484212A5034365278 @default.
• W1863484212 hasAuthorship W1863484212A5044801113 @default.
• W1863484212 hasAuthorship W1863484212A5045950154 @default.
• W1863484212 hasAuthorship W1863484212A5049279715 @default.
• W1863484212 hasAuthorship W1863484212A5054489737 @default.
• W1863484212 hasAuthorship W1863484212A5081844624 @default.
• W1863484212 hasAuthorship W1863484212A5086784384 @default.
• W1863484212 hasAuthorship W1863484212A5087007057 @default.
• W1863484212 hasAuthorship W1863484212A5090210646 @default.
• W1863484212 hasBestOaLocation W18634842121 @default.
• W1863484212 hasConcept C107130276 @default.
• W1863484212 hasConcept C126322002 @default.
• W1863484212 hasConcept C143998085 @default.
• W1863484212 hasConcept C2908647359 @default.
• W1863484212 hasConcept C512399662 @default.
• W1863484212 hasConcept C71924100 @default.
• W1863484212 hasConcept C72563966 @default.
• W1863484212 hasConcept C74909509 @default.
• W1863484212 hasConcept C99454951 @default.
• W1863484212 hasConceptScore W1863484212C107130276 @default.
• W1863484212 hasConceptScore W1863484212C126322002 @default.
• W1863484212 hasConceptScore W1863484212C143998085 @default.
• W1863484212 hasConceptScore W1863484212C2908647359 @default.
• W1863484212 hasConceptScore W1863484212C512399662 @default.
• W1863484212 hasConceptScore W1863484212C71924100 @default.
• W1863484212 hasConceptScore W1863484212C72563966 @default.
• W1863484212 hasConceptScore W1863484212C74909509 @default.
• W1863484212 hasConceptScore W1863484212C99454951 @default.
• W1863484212 hasIssue "13" @default.

• next